Back to search

Article

Noradrenergic signaling controls Alzheimer's disease pathology via activation of microglial β2 adrenergic receptors

2024-02-26

Abstract excerpt

<title>Abstract</title> <p>Norepinephrine (NE) is a potent anti-inflammatory agent in the brain. In Alzheimer’s disease (AD), the loss of NE signaling heightens neuroinflammation and exacerbates amyloid pathology. NE inhibits surveillance activity of microglia, the brain’s resident immune cells, via their β2 adrenergic receptors (β2ARs). Here, we investigate the role of microglial β2AR signaling in AD pathology i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
976e0e56-4cc9-500a-b055-2615fe36781f
DOI
10.21203/rs.3.rs-3976896/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Noradrenergic signaling controls Alzheimer's disease pathology via activation of microglial β2 adrenergic receptorsDOI 10.21203/rs.3.rs-3976896/v1
Select a neighboring publication to make it the new centre.